key: cord-0301585-jeqeal04
authors: Koulouras, Grigorios; Frith, Martin C.
title: Significant non-existence of sequences in genomes and proteomes
date: 2020-06-25
journal: bioRxiv
DOI: 10.1101/2020.06.25.170431
sha: 0700f7e0900668d65915b997966732ac5b35de05
doc_id: 301585
cord_uid: jeqeal04

Nullomers are minimal-length oligomers absent from a genome or proteome. Although research has shown that artificially synthesized nullomers have deleterious effects, there is still a lack of a strategy for the prioritisation and classification of non-occurring sequences as potentially malicious or benign. In this work, by using Markovian models with multiple-testing correction, we reveal significant absent oligomers which are statistically expected to exist. This strongly suggests that their absence is due to negative selection. We survey genomes and proteomes covering the diversity of life, and find thousands of significant absent sequences. Common significant nullomers are often mono- or dinucleotide tracts, or palindromic. Significant viral nullomers are often restriction sites, and may indicate unknown restriction motifs. Surprisingly, significant mammal genome nullomers are often present, but rare, in other mammals, suggesting that they are suppressed but not completely forbidden. Significant human nullomers are rarely present in human viruses, indicating viral mimicry of the host. More than 1/4 of human proteins are one substitution away from containing a significant nullomer. We provide a web-based, interactive database of significant nullomers across genomes and proteomes.

The terms minimal absent words (MAWs) and nullomers both describe the shortest sequences that do not occur in the entire genome or proteome of an organism. Although many biotechnological applications have been envisioned, from potential selective drugs (1) (2) to forensic practice (3) , the actual role of nullomers has intensely been debated (4) and still remains enigmatic. Lately, fast tools and efficient algorithms have been introduced making the discovery of globally missing sequences practical (5-8, 42, 56-57) . In 2012, Alileche and colleagues demonstrated that two absent 5-amino-acid peptides cause fatal damage to cancer cells (2) , while 5 years later Alileche and Hampikian showed that the same MAWs have a broad lethal effect on cancer cell lines derived from nine organs represented in the NCI-60 panel (1) . Additionally, Silva and colleagues have reported that three minimal 12-nucleotide fragments entirely absent from the human genome, appear consistently at the same location in two protein-coding genes of Ebola virus genomes (9) . Although there exists an unambiguous sequence conservation in their findings, it is not clear whether the absence of these oligomers is statistically expected. In the same study, the term minimal relative absent words (RAWs) is introduced, describing sequences that are present in a pathogenic organism but absent from its host. On one hand, all the above findings ideally support the conjecture that MAWs may have gone extinct due to evolutionary pressure or putative deleterious effects. Perhaps the unfavourable properties of nullomers are linked with forbidden spatial conformations followed by functional consequences incompatible with life. Hence, the structural arrangements of globally absent motifs and the putative perturbation of molecules upon their appearance (i.e. emergence of a nullomer upon a mutation) form an interesting area for future research. Conversely, a finite set of sequences, for example the entire genome or proteome of a species, does not include all the different combinations of elements from the alphabet it is composed of, due to the fact that the combination of residues in a sequence increases exponentially with its length. Therefore, it still remains a riddle whether the absence of a nullomer is, in fact, an evolutionary consequence linked with adverse effects or a product of randomness. NCBI Genome (35; ftp://ftp.ncbi.nlm.nih.gov/genomes/). We developed custom Python scripts to discard headers and concatenate sequences from multiple fasta files, to produce files with one header and one-line sequence for each organism. The above step was applied to protein sequences as well, because MAW and em-MAW are developed in a way to calculate nullomers of each individual record in a fasta file. For the identification of peptide nullomers, we combined information both from the Swiss-Prot and TrEMBL sections of UniProtKB including protein isoforms. The redundant but slightly different sequences (isoforms) that were included in this step can contribute to the elimination of incorrectly identified MAWs. Moreover, the incorporation of predicted with manually reviewed records produces a list of more confident non-occurring sequences. The final pre-processing step included the removal of any ambiguous residues (character N in genomes or B, J, X, Z in proteins). Eventually, we generated lists of global nullomers from various species which were used as an input for downstream analysis in Nullomers Assessor.

Statistical models represent the observed variability in data by probability distributions. A simple model of a sequence = ( 1, 2, 3, . . . ) is a first-order Markov chain, where each position is dependent only on its immediate precursor. For example, the probability of observing a 'G' at one position depends (only) on whether there is a 'C' in the previous position. This can be expressed as:

In our method, we consider genomes and proteomes (hereinafter background sequence) as Markov chains. A first order Markov chain is a model where each position is contingent merely on its previous position. Likewise, in an -th order Markov chain, each position depends on the previous positions.

In order to decide whether a nullomer is statistically expected to exist, we estimate Markov probabilities.

First, the frequencies of elements (nucleotides or amino acids) of the background sequence are calculated. Then, three Markov probability matrices are generated, one for each of the first three Markov model orders. In general, a substitution matrix for distinct letters (e.g. = 4 for DNA) and order , is a grid of * probabilities. As an example, a stochastic matrix of third-order for all the naturally occurring amino acid residues in a bacterium (20 distinct amino acids assuming that neither selenocysteine nor pyrrolysine are present) requires a matrix of 20 * 20 3 = 160.000 cells (namely 20 rows and 20 3 columns, or vice versa). Each of these 160.000 probabilities indicate the likelihood for a specific amino acid to occur given the three preceding amino acids.

In non-mathematical terms, each residue of a biological sequence is dependent on the previous elements, where defines the order of a Markovian process. Implicitly, a stochastic process in a biological sequence can reveal the sequential preferences among neighboring residues as well as reflect avoided motifs which may introduce an unfavorable structural folding. We utilised the abovedescribed fundamental mathematical notion and developed a custom Python script (Nullomers Assessor) which approximates the likelihood for a nullomer to occur zero times based on the first four orders of Markovian chains (including zeroth order). More precisely, four distinct p-values are assigned to each nullomer of the list. To elucidate and put this probabilistic property into a more biological context, we provide the following example. Assuming the peptide 'PTILA' is an absent minimal 5-mer, then the probability of being entirely absent based on a second-order Markov chain can be calculated as illustrated below:

Initially, the probability of 'PTILA' to occur is estimated (Equation 2). In this formula, P(P) denotes the observed frequency of proline in the entire background sequence. Subsequently, P(T|P) signifies the probability of threonine to arise after a proline. Similarly, P(I|TP) indicates the probability of isoleucine to occur given the previous 2 adjacent amino acids are a proline followed by a threonine, and so forth.

Next, the expected number of occurrences for the specific actual nullomer is estimated (Equation 3), a value that is used for the final estimation of the second order zero-occurrence probability (Equation 4).

In a similar manner, the probabilities of first and third orders are computed, while the zeroth order simply mirrors the frequency of residues in the background sequence. In simple words, the calculated p-values represent the probability of a minimal absent word to be indeed absent based on the rate at which the residues occur as well as three additional transition probabilities which reflect the frequency of 2-, 3-, and 4-mers of the examined genome or proteome.

Although 4 different probabilities are calculated, the maximum p-value is kept and assigned to each examined nullomer. Since a p-value denotes the chance of a nullomer to occur exactly zero times (namely to be absent), then the lower the value, the more expected the nullomer is to exist (or equivalently the less expected it is to be, indeed, absent). By keeping the highest probability amongst the 4 calculated p-values, we expect to end up with fewer but more confidently true-positive results.

There is a large number of short sequences that each have a chance of being absent. Therefore, the emergence of false positive results must be controlled (46) . More specifically, all the 4 calculated p- Alternatively, in the Benjamini-Hochberg procedure, the probabilities are sorted in descending order and sequentially rejected if the product of a p-value and the number of remaining tests is greater than a cut-off limit. The FDR method though, which constitutes a milder alternative, performs markedly loosely when applied to large eukaryotic genomes resulting in thousands of significant nullomers. This motivated us to incorporate a third correction option, the Tarone methodology. This is a special case of the Bonferroni method, where we make it less conservative by doing fewer tests. For a given wordlength k, we calculate the zero-occurrence probability (the maximum of the four Markov probabilities)

for each of the 4 k-mers. Then, these 4 k-mers are ordered in descending order of zero-occurrence probability. Next, we exclude from testing any k-mer whose absence would not be significant because the Bonferroni-adjusted p-value is above a cut-off threshold:

Equation (6) represents the mathematical notation of the Tarone method, where counter denotes a number which progressively increases by 1 when a k-mer is excluded from testing. Finally, the "testable" k-mers that remain are compared to the actual nullomers in the list, and those in the intersection are output. In this way, the stringent nature of Bonferroni remains, whilst a milder adjustment is performed every time a test is excluded due to impossibility of significance.

Next, we tested the accuracy and rigour of the 3 different correction methods using a common dataset and a constant threshold of false discovery control. The results show that Bonferroni correction performs the strictest cleansing of false positive nullomers (very likely at the cost of increased false negatives), followed by the Tarone method, whereas the FDR approach constitutes the least stringent alternative.

More precisely, any result-set derived by Bonferroni is a subset of the corresponding Tarone set, while the results of the FDR method almost always include all the above outcomes. Throughout our analysis, a fixed false discovery threshold of 1% has been applied, both when searching for genomic or peptide nullomers. In order to eliminate the emergence of Type I errors to the utmost degree, we report a nullomer as significant only when all four corrected probabilities are lower than the user specified cutoff. However, we advise users to apply Bonferroni correction to relatively large genomes, in order to control as much as possible the emergence of false-positive results, whilst starting with an alternative method when dealing with either small genomes (i.e. viruses or microbe datasets) or proteomes in general.

Random sequence shuffling is a widely used approach to evaluate stochasticity as well as statistical significance of results. In order to evaluate the rigour of our method, especially because Equation (4) is only approximately true, we performed permutation tests by randomly shuffling the human proteome.

Since Nullomers Assessor calculates up to third-order probabilities, we sought to retain unaltered not only the counts of distinct amino acids, but also higher-order statistics, such as the frequency of adjacent letters (doublets and triplets) of the entire proteome. For this purpose, we used a sophisticated shuffling algorithm, uShuffle (21) , which performs random shuffling of sequences while preserving -let counts. The C# software package of the uShuffle method was used to shuffle the human proteome 10 times while preserving the frequency of amino acids, doublet occurrences and tripeptides. Next, for each of the 10 shuffled proteomes we re-generated lists of nullomers in order to examine whether any of the new random absent sequences would come into view as significant. By keeping the singlet, doublet, and triplet amino acid frequencies unchanged but not their order, we expected to end up with utterly different lists of nullomers. We used the original human proteome as a background sequence and re-ran our method 10 times (once per each new list of nullomers) in order to assess the newly created lists of 'counterfeit' absent words. Even though the script was executed using identical parameters (background proteome, correction method, threshold of statistical significance), no significant results emerged in any of the 10 attempts, demonstrating the stringency of our methodology.

Thus, we assessed 10 sets of random missing sequences using the real transition probabilities of the reference human proteome given the fact our method scans any background sequence by considering frequencies up to 4-mers (precisely up to third-order Markov chains). The outcome of this step strongly suggests that Nullomers Assessor is able to disclose truly significant nullomers.

In the present study, we rigorously assess absent sequences for their statistical significance. We examine genomes and proteomes from hundreds of organisms (Table 1 ) and show lists of nullomers which are unexpected to be absent, in contrast with other missing sequences. Our findings demonstrate that several thousands of absent sequences are statistically expected to occur in various genomes. The longest significant human genomic MAW is composed of 13 nucleotides, whilst the lengthiest significant peptide nullomer from the same organism is 5 residues long. After applying our method to the entire human genome, 13 significant genomic nullomers stood out (Bonferroni correction at 1% cut-off) from a set of more than 27 million non-occurring oligomers. In essence, the specific 13 missing words are highly statistically foreseen to occur somewhere in the human genome but, in reality, they are totally absent. In a similar manner, we analysed peptide nullomers from the human and mouse proteomes.

Thirteen absent peptides from the human proteome were classified as significant when the Tarone correction method was used, while eight peptides emerged when we applied identical parameters to the mouse proteome (Table 3) . Moving the hypothesis of harmfulness a step forward, we systematically explored nullomer-making mutations which are one residue away from the reference sequence. More specifically, we calculated all the possible single amino acid substitutions in all protein records of each proteome that can give rise to any of the total 21 significant absent words. This might offer useful insights for unravelling plausible mechanisms of evolvability that underlie peptide nullomers. Prior research suggests that different residues differ in respect of their mutational preference (41) and reports implications in phosphorylation sites (37) . Therefore, the mutational landscape of nullomers presented in this work, may provide a useful resource for future sequencing studies, especially in the field of proteomics (40) . To this end, we highlight and share more than 30 Table 2 ).

To assess whether nullomers have an ancestral origin, we examined a plethora of diverse organisms ranging from bacteria to human. To this end, we hypothesized that distantly-related genomes would share fewer similar sequence features and therefore one would not be surprised to find fewer or no nullomers in common. In contrast, despite the stringent filtering criteria of our methodology, we would expect to end up with identical significant nullomers from closely-related organisms due to the existing high similarity both in genomic and protein sequences. Surprisingly, while some significant nullomers are sporadically shared by some mammals, most are not shared by closely-related mammals ( Figure   1 ) Figure   2A ). In a like manner, the estimated median frequency of chimp-derived nullomers in the human genome is 53 ( Figure 2B ) while the detailed dataset is provided in Supplementary Table 3 . Figure 2C and 2D outline a similar trend in nullomers of Mus musculus and Canis lupus familiaris, respectively, where the expected number of occurrences is again more than the actual observations. This finding suggests an alternative hypothesis in which significant nullomers are not completely forbidden, but they are strongly suppressed. Strongly suppressed sequences are expected to occur just a few times, so by chance fluctuations some of them could appear zero times.

In contrast, none of the roughly 2.850 unique significant nullomers in vertebrates are shared with any of the other species which belong to archaea, bacteria, protozoa, or fungi ( Figure 3A ). To some extent, this may be due to the heterogenous complexity among species of different kingdoms because significant nullomers of vertebrates are usually longer ( Figure 3B ). Overall, these observations are in accordance with findings reported by Acquisti et al. (4) . The authors of that study have demonstrated that species with a more-recent common ancestor share more MAWs in common in comparison with more distantly-related organisms. Here, we provide evidence that more-closely related organisms share not only common deficits in general, but also some identical significant missing patterns, supporting the hypothesis of evolutionarily-conserved aversion to these sequences.

Furthermore, we observed multiple genomic MAWs in common across species ranging from 6 to 14 residues. Table 2 presents the most frequent significant nucleotide sequences whose absence is shared between at least 18 species, while a complete list is in Supplementary Table 4 

According to the definition, a nullomer is a minimal-length sequence that does not occur within a longer sequence. Consequently, if we think of a − 1 peptide derived from a nullomer of length without either the first or the last amino acid, then the remaining part of − 1 residues certainly occurs somewhere in the background sequence. This information is enough to identify regions in proteins that are susceptible to create a significant nullomer upon a mutation. Additionally, single amino acid alterations capable of generating a nullomer can occur in non-edge positions of a k-mer. To illustrate this point further, we provide the following example. BRCA1 is a human gene that produces a tumour suppressor protein of damage repair and embryonic development (38, 39) . What can be seen in Figure 5 is that dominant mutational trends remain unaffected either with or without predicted records.

Recently, massive efforts have been put forth to prioritize the functional importance of phosphorylation sites (54, 55) as well as decipher correlation between mutation and phosphorylation in cancer (75) . For this reason, we compiled a curated list of susceptible nullomer-making phosphosites retrieved from PhosphoSite Plus database (36) . Our analysis revealed 176 phosphorylation sites of high confidence which are prone to give rise to a nullomer (Supplementary Table 1) , whilst a similar tendency is notable where valine is the most prominent mutational target ( Figure 6 ). Future research should be devoted to characterizing the impact of nullomer-making mutations, especially when a substitution occurs in post translational modification (PTM) sites.

Recent studies have shown that viral sequences mimic those of their hosts, to some extent, in part to evade immune responses (32, (50) (51) , and this can be used to predict viral hosts (33) . To this end, we set out to survey virus genomes and proteins and investigate whether the scenario of RAWs fits with our previous human-derived findings. Viral sequences and complementary annotation were downloaded from NCBI Virus (43) in March 2020. We filtered out incomplete sequences, whilst we further discarded records that have been isolated from non-human species, resulting to 33.610 genomes and 233.178 proteins. Next, we queried whether significant human nullomers appear in any of the viral sequences. We observed that 5 genomic nullomers (out of the total 13) were present in 39 unique sequences of 3 distinct virus families ( Figure 7A ). What stands out is the remarkably low number of significant human-RAWs which are present in the virus genomes (Supplementary Table 2 ). In other words, there is a general absence of absent human sequences that are present in viruses.

Likewise, we investigated whether human-derived peptide nullomers are present in viral protein sequences. We observed that 10 out of the 13 significant human MAWs emerge in various proteins of to 10 residues were revealed significant upon Bonferroni correction at 1% cut-off. A wide species coverage is observed since the overall motifs are absent from more than 6.000 distinct species whereas, interestingly enough, the most frequent missing sequences are recognition sites of host restriction enzymes, according to the Restriction Enzyme Database (65; http://rebase.neb.com/). Restriction enzymes present in prokaryotes recognise specific sequential patterns in viruses and cleave their DNA sequences into fragments (66) (67) . These cutter enzymes provide a defence mechanism in host species against virus invasion and have been successfully utilized in a range of biotechnological applications and research studies (68) (69) (70) (71) (72) . Although it is known that restriction sites confer a selective disadvantage to viruses, this has not been previously linked to nullomers. The fact that our top hits include several palindrome sequences ranging from 4 to 6 bases in length offers potential for virus nullomers to be utilised as predictors of previously unknown restriction motifs in host organisms. Furthermore, given the robustness of our evaluation method, the entire dataset can offer a valuable resource for future in silico research. Table 5 presents the most frequent virus nullomers which are shared between hundreds of viral species while the entire list is provided in the form of a spreadsheet (Supplementary Table 5 ) as well as through Nullomers Database.

To make the nullomers of the current study easily accessible and explorable, we developed an online portal available at https://www.nullomers.org. Nullomers Database aims to serve as a central hub of information for further investigation of minimal absent words. The provided results are significant identified genomic and peptide nullomers assessed by Nullomers Assessor. Main emphasis has been given to peptide nullomers and, more specifically, to regions of proteins that are prone to give rise to a significant nullomer upon a single amino acid alteration. Assuming that the deficit of the shortest absent words is governed by evolutionary factors with unfavourable consequences, then one would expect that the emergence of a nullomer upon a mutation would possibly have a negative effect. To prevent outdated information remaining in Nullomers Database, complex stored procedures have been developed in conjunction with an automated communication channel which retrieves information from

UniProt. The gene name, protein sequence, description, sequential annotation as well as protein status (i.e. whether a protein is still active or has been deprecated and moved to UniProt Archive) are asynchronously collected from UniProt via a REST web-service. Moreover, in order to assess the significance and determine the effect of putative nullomer-making mutations, we provide functional impact annotation by Mutation Assessor (22, 23) , a server which predicts functional consequences of amino acid alterations. Given the dynamic nature of the UniProt database, the information retrieval of all the above-described steps has been automated, making Nullomers Database a fully autonomous, scalable, and frequently updated repository. Additionally, the integration of MolArt (24) , an interactive visualization plugin (Figure 9 ), allows for the simultaneous exploration of multiple sequential and structural features in protein nullomers. The interconnected and synchronized panels of MolArt permit users to identify co-occurrent elements in regions that are prone to engender a missing word upon a single amino acid substitution. The entire sequence annotation of the plugin is retrieved from UniProt in real-time whereas the corresponding experimental structures are dynamically fetched from Protein DataBank (or from Swiss Model Repository when a structure is not available). Therefore, the specific functionality of Nullomers Database ensures that the provided information can always be in line with major protein databases and automatically be enriched over time.

This paper introduces Nullomers Assessor, a probabilistic protocol provided as an open-source software tool, for the assessment of any set of minimal absent genomic or peptide sequences. The software offers a rigorous way of filtering missing words by Markov chains, while three statistical correction methods are available to control false positive results. We applied the script to entire genomes of hundreds of species and observed that numerous nullomers are statistically significant in multiple organisms. Moreover, we systematically examined more than 147.000 individual virus sequences and observed that the most frequent significant absent motifs are restriction recognition sites. In addition to the prevailing hypothesis that minimal absent words have gone extinct due to negative selection, we suggest that nullomers may have been replaced by more specialized sequences, which execute similar or even optimized functions.

We analysed the human and mouse proteomes and identified positions that are prone to introduce a significant missing peptide. We found that more than one fourth of human proteins can give rise to a significant nullomer upon a single amino acid substitution. We freely provide our findings in a visual, interactive, and user-friendly way via Nullomers Database. Taking advantage of the powerful functionalities that modern web technologies provide, we highlight protein positions which can generate a minimal absent word in their sequences.

In summary, the present study reveals significant nullomers that are unlikely to be absent by chance.

Further studies should be conducted to experimentally validate and determine the actual role of nullomers as well as the extent of harmfulness behind nullomer-making mutations; hence, we anticipate that both Nullomers Assessor and Nullomers Database can be useful resources and facilitate research towards a better understanding of the still mysterious role of minimal absent words. 12-mer 0 0 0 1 13-mer 0 0 0 0 Table 5 . List of the most frequent (present in >1.000 distinct sequences) significant nullomers in viruses.

The effect of Nullomer-derived peptides 9R, 9S1R and 124R on the NCI-60 panel and normal cell lines

Nullomer derived anticancer peptides (NulloPs): differential lethal effects on normal and cancer cells in vitro

Safeguarding forensic DNA reference samples with nullomer barcodes

Nullomers: really a matter of natural selection?

Linear-time computation of minimal absent words using suffix array

emMAW: computing minimal absent words in external memory

On finding minimal absent words

Efficient computation of absent words in genomic sequences

Three minimal sequences found in Ebola virus genomes and absent from human DNA

Natural vs. random protein sequences: Discovering combinatorics properties on amino acid words

The dark side of the human genome

Exploring the dark genome: implications for precision medicine

Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-metabolic complications

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

The impact of rare and low-frequency genetic variants in common disease

Peptide therapeutics: current status and future directions

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

Annotating non-coding regions of the genome

Statistical features of human exons and their flanking regions

Markov model plus k-word distributions: a synergy that produces novel statistical measures for sequence comparison

uShuffle: a useful tool for shuffling biological sequences while preserving the k-let counts

Determinants of protein function revealed by combinatorial entropy optimization

Predicting the functional impact of protein mutations: application to cancer genomics

MolArt: a molecular structure annotation and visualization tool

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Semi-supervised learning of Hidden Markov Models for biological sequence analysis

JUCHMME: a Java Utility for Class Hidden Markov Models and Extensions for biological sequence analysis

Alignment-free method for DNA sequence clustering using Fuzzy integral similarity

The BaMM web server for de-novo motif discovery and regulatory sequence analysis

UniProt: a worldwide hub of protein knowledge

Dinucleotide Composition in Animal RNA Viruses Is Shaped More by Virus Family than by Host Species

Patterns of evolution and host gene mimicry in influenza and other RNA viruses

Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes

CG dinucleotide suppression enables antiviral defence targeting non-self RNA

Database resources of the National Center for Biotechnology Information

2014: mutations, PTMs and recalibrations

Mutational properties of amino acid residues: implications for evolvability of phosphorylatable residues

Mechanisms of BRCA1 tumor suppression

In brief: BRCA1 and BRCA2

Proteogenomic Analysis of Protein Sequence Alterations in

Prominent features of the amino acid mutation landscape in cancer

Efficient computation of shortest absent words in complete genomes

Virus Variation Resource -improved response to emergent viral outbreaks

VISDB: a manually curated database of viral integration sites in the human genome

Viral sequences in human cancer

How does multiple testing correction work

Controlling the false discovery rate: A practical and powerful approach to multiple testing

A modified Bonferroni method for discrete data

Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication

A possible role for autoimmunity through molecular mimicry in alphavirus mediated arthritis

Middle East respiratory syndrome

The severe acute respiratory syndrome

The functional landscape of the human phosphoproteome

Illuminating the dark phosphoproteome

keeSeek: searching distant non-existing words in genomes for PCR-based applications

Efficient computation of shortest absent words in a genomic sequence

The EMBL-EBI search and sequence analysis tools APIs in 2019

Structure, Function, and Evolution of Coronavirus Spike Proteins

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

WebLogo: a sequence logo generator

Epigenetic engineering of yeast reveals dynamic molecular adaptation to methylation stress and genetic modulators of specific DNMT3 family members

Molecular mechanism of translational stalling by inhibitory codon combinations and poly(A) tracts

Impact of poly(A)-tail G-content on Arabidopsis PAB binding and their role in enhancing translational efficiency

REBASE--a database for DNA restriction and modification: enzymes, genes and genomes

Restriction endonucleases

Molecular evolution of bacteriophages: evidence of selection against the recognition sites of host restriction enzymes

DNA modification and restriction

Bacteriophage survival: multiple mechanisms for avoiding the deoxyribonucleic acid restriction systems of their hosts

Site-selective scission of human genome using PNA-based artificial restriction DNA cutter

Development of a Simple and Quick Method to Assess Base Editing in Human Cells

Bacterial non-specific nucleases of the phospholipase D superfamily and their biotechnological potential

REHUNT: a reliable and open source package for restriction enzyme hunting

InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams

Proteogenomic Characterization of Human Early-Onset Gastric Cancer

Synonymous Dinucleotide Usage: A Codon-Aware Metric for Quantifying Dinucleotide Representation in Viruses

We thank and acknowledge helpful conversations with Sara Zanivan (